期刊文献+

17国国家药物政策的系统评价 被引量:21

A Systematic Review of National Drug Policy in Seventeen Countries
下载PDF
导出
摘要 目的系统评价和分析17国国家药物政策的主要内容,为建立适合我国国情的国家药物政策提供决策依据。方法共检索13个电子数据库、WHO、世界银行和17国药品管理相关网站,用预先设计的数据提取表收集相关信息,根据设计的理论框架对提取的信息进行分析和描述。结果共纳入17个国家的182篇文献,各国药物政策共同关注的要点是:药品规制和质量保障、合理用药、药品供应、基本药物遴选、人力资源开发与培训、传统医药、药品筹资和可支付能力、药品研究、药物政策的监测和评估、技术合作和本国医药产业发展。我国在药物遴选、质量保障、供应、定价及传统医药等方面开展工作,而对药品研究、政策监测、本国医药发展和技术合作方面还有待进一步加强。结论建议筹备相关组织机构和规范工作程序,推动国家基本药物政策相关立法工作,健全基本药物目录的遴选机制和配套实施政策,整顿药品生产流通秩序,建立科学合理的药品定价机制和基本药物可及性评估体系,加强药物政策的监测与评估,适时更新和完善国家药物政策。 Objectives To analyze the development and implementation of the national drug policy in order to provide decision-making for the establishment of the Chinese national drug policy. Methods Nineteen electronic databases, the WHO, the World Bank, and governmental websites were included in this study. A pre-designed data extraction form was used to collect information. The data were analyzed and described by a pre-designed analytic framework. Result A total of 182 studies were included in this review. The main points of common concern in the national drug policy were: drug regulation and quality assurance, rational use of drugs, drug supply, the selection of essential drugs, human resource development and training, traditional medicine, drug financing and affordability, drug research, monitoring and assessment of the nation drug policy, technical cooperation, and the national pharmaceutical industry. The selection of essential drugs, quality assurance, supply, pricing, and supply of traditional medicine were gradually carried out in China. Pharmaceutical research, monitoring and evaluation, as well as the development of pharmaceutical industry and technical cooperation within it should be further strengthened. Conclusion China should establish related organizations and working procedures; speed up the imp/ementation of the legislation of national drug policy; integrate the mechanism of essential drugs selection and supply system; regulate the order of medicine production and regulation; establish scientific and reasonable pricing mechanisms for drugs and assessment systems; strengthen the monitoring and evaluation of national drug policy and update and improve the national drug oolicy.
出处 《中国循证医学杂志》 CSCD 2009年第7期715-729,共15页 Chinese Journal of Evidence-based Medicine
基金 卫生部卫生统计信息中心卫生政策支持项目(HPSP)资助
关键词 国家药物政策 基本药物 系统评价 National drug policy Rational use of drugs Selection of essential drugs
  • 相关文献

参考文献185

  • 1WHO.How to develop and implement a national drug policy.http://whqlibdoc.who.int/hq/2002/WHO_EDM_TRM_2002.1 _chi.pdf.2008.12.
  • 2WHO.WHO Medicines Strategy:2004-2007,Countries at the core.http://www.who.int/medicinedocs/collect/medicinedocs/pdf/ s5416e/s5416e.pdf.2008.12.
  • 3覃正碧,汪志宏,程刚,李元启,左小平,卢祖洵,向继洲.国家基本药物制度的现状及其完善对策探讨[J].中国药房,2008,19(14):1041-1044. 被引量:59
  • 4Unknown,2009年全国卫生会议工作召开,陈竺:做好六项工作.http://www.gov.cn/gzdt/2009-01/08/content_1199449.htm.2009.1.
  • 5Zweygarth M,Summers RS.A national database for essential drugs in South Africa.Pharm World Sci,2000,22(3):116-117.
  • 6Tomson G,Paphassarang C,Jonsson K,et al.Decision-makers and the usefulness of research evidence in policy implementation-A case study from Lao PDR.Soc Sci Med,2005,61(6):1291-1299.
  • 7Stenson B,Tomson G,Syhakhang L.Pharmaceutical regulation in context:the case of Lao People's Democratic Republic.Health Policy Plan,1997,12(4):329-340.
  • 8Paphassarang C,Wahlstrom R,Phoummalaysith B,et al.Building the National Drug Policy on evidence:A cross sectional study on assessing implementation in Lao PDR.Southeast Asian Journal of Tropical Medicine & Public Health,2002,33(3):647-653.
  • 9Chaulagai CN.Community financing for essential drugs in Nepal.World Health Forum,1995,16(1):92-94.
  • 10Scott DL,Alder S,Usui E,et al.Orphan drug programs/policies in Australia,Japan,and Canada.Drug Informationlournal,2001,35(1):1-16.

二级参考文献49

  • 1陈永法,邵蓉.在实践中不断完善国家基本药物政策[J].中国药业,2005,14(3):2-3. 被引量:17
  • 2曹建军,曾安平.药品价格:问题、原因与对策(上)[J].中国物价,2005(4):12-16. 被引量:6
  • 3施勇杰.医药价格现状、根源及对策[J].中国经贸导刊,2005(14):43-44. 被引量:2
  • 4胡善联,张新建(组稿).基本药物是什么?[J].中国卫生,2007(6):49-50. 被引量:5
  • 5吴蓬主编.药事管理学 第2版[M].北京:人民卫生出版社,2001..
  • 6[1]Idanpaan Heikkila JE.Essential drugs[J].Ann Med,1993,25(1):19.
  • 7[2]Couper MR.The selection of essential drugs:A review [J].Chin J Clin Pharmacol,1993,9(1):3.
  • 8[4]Richard Laing, Brenda Waning, Andy Gray.25 years of the WHO essential medicines lists: progess and challenges[J]. Lancet, 2003,361:1 723.
  • 9[5]Executive Board WHO.Revised procedures for updating the WHO model list of essential drugs: a summary of proposals and processes[R] . EB108/INF. DOC./2.Geneva :World Health Organization, 2001.
  • 10FDA. Center For Drug Evaluation and Research List of Guidance Documents. CDER Guidance Document, 2004, 3.

共引文献122

同被引文献245

引证文献21

二级引证文献358

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部